Haw Par Corp. Ltd. (HAWPF)
10.80
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Haw Par Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 9.448M |
| September 30, 2019 | 41.31M |
| June 30, 2019 | 66.36M |
| March 31, 2019 | 16.29M |
| December 31, 2018 | 14.87M |
| September 30, 2018 | 41.84M |
| June 30, 2018 | 61.49M |
| March 31, 2018 | 14.66M |
| December 31, 2017 | 10.76M |
| September 30, 2017 | 29.31M |
| June 30, 2017 | 36.85M |
| March 31, 2017 | 11.78M |
| December 31, 2016 | 12.24M |
| September 30, 2016 | 31.32M |
| June 30, 2016 | 35.62M |
| March 31, 2016 | 12.17M |
| December 31, 2015 | 13.51M |
| September 30, 2015 | 25.12M |
| June 30, 2015 | 86.21M |
| March 31, 2015 | 9.915M |
| December 31, 2014 | 14.15M |
| September 30, 2014 | 21.29M |
| June 30, 2014 | 47.50M |
| March 31, 2014 | 9.589M |
| December 31, 2013 | 19.12M |
| Date | Value |
|---|---|
| September 30, 2013 | 17.63M |
| June 30, 2013 | 42.16M |
| March 31, 2013 | 6.184M |
| December 31, 2012 | 28.25M |
| September 30, 2012 | 16.42M |
| June 30, 2012 | 35.20M |
| March 31, 2012 | 5.769M |
| December 31, 2011 | 11.72M |
| September 30, 2011 | 6.105M |
| June 30, 2011 | 38.21M |
| March 31, 2011 | 5.311M |
| December 31, 2010 | 21.36M |
| September 30, 2010 | 22.07M |
| June 30, 2010 | |
| March 31, 2010 | 5.256M |
| December 31, 2009 | -10.16M |
| September 30, 2009 | 15.32M |
| June 30, 2009 | 27.26M |
| March 31, 2009 | 6.040M |
| December 31, 2008 | 2.746M |
| September 30, 2008 | 15.09M |
| June 30, 2008 | 32.55M |
| March 31, 2008 | 6.314M |
| December 31, 2007 | 50.71M |
| September 30, 2007 | 17.90M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| AstraZeneca PLC | 3.076B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Avadel Pharmaceuticals Plc | 0.02M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | 2.051B |
| Earnings Yield | 7.46% |
| Operating Earnings Yield | 2.18% |
| Normalized Earnings Yield | 7.465 |